Hjem › Ikke-småcellet lungekreft › California › Mountain View
Kliniske studier for Ikke-småcellet lungekreft i Mountain View, CA
21 studier for Ikke-småcellet lungekreft søker deltakere på steder i og rundt Mountain View (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
RekruttererFase 1/2
- Stanford Cancer Institute (Melanoma/NSCLC), Stanford · 5 mi unna
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekruttererFase 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · 5 mi unna
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi unna
Adaptive ctDNA-Based Personalization of Treatment During Consolidation Therapy in NSCLC
RekruttererFase 3
- Stanford University, Stanford · 5 mi unna
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
RekruttererFase 2
- Stanford Cancer Institute, Stanford · 5 mi unna
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RekruttererObservasjonsstudie
- Stanford University, Palo Alto · 5 mi unna
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
RekruttererFase 2
- Stanford Cancer Institute, Stanford · 5 mi unna
- Stanford Hospital and Clinics, Stanford · 5 mi unna
- Stanford Hospital Investigational Drug Services, Stanford · 5 mi unna
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
RekruttererFase 3
- Stanford Cancer Center, Palo Alto · 5 mi unna
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekruttererFase 1/2
- Stanford Cancer Institute, Stanford · 5 mi unna
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
RekruttererFase 1/2
- Stanford University Medical Center - Neurology, Stanford · 5 mi unna
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RekruttererFase 3
- Palo Alto Medical Foundation Research Center, Palo Alto · 5 mi unna
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
RekruttererFase 1/2
- Stanford Cancer Institute, Stanford · 5 mi unna
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
RekruttererFase 1/2
- Stanford University Medical Center, Stanford · 5 mi unna
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
RekruttererFase 1
- Stanford University Medical Center, Palo Alto · 5 mi unna
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
RekruttererFase 1
- Stanford University, Palo Alto · 5 mi unna
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
RekruttererFase 1/2
- Stanford University - Stanford Cancer Institute, Stanford · 5 mi unna
A Study of LY4175408 in Participants With Advanced Cancer
RekruttererFase 1
- Stanford Medicine Cancer Center, Stanford · 5 mi unna
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
RekruttererFase 1/2
- Stanford University, Stanford · 5 mi unna
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
RekruttererFase 1/2
- Stanford Women's Cancer Center, Palo Alto · 5 mi unna
Engagement of Veterans With Lung Cancer
Rekrutterer
- Veterans Affairs Palo Alto Health Care System (VAPAHCS), Palo Alto · 5 mi unna
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Stanford · 5 mi unna
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
RekruttererFase 1
- Stanford University, Stanford · 5 mi unna
Ikke-småcellet lungekreft-studier i andre byer
- Houston, TX145 studier
- New York City, NY121 studier
- Arlington, VA104 studier
- Nashville, TN97 studier
- Boston, MA90 studier
- Los Angeles, CA87 studier
- St. Louis, MO73 studier
- Chicago, IL61 studier
- Baltimore, MD60 studier
- San Antonio, TX59 studier
- Columbus, OH57 studier
- Washington, DC55 studier
Andre studier i Mountain View
- Kreft (alle typer)40 studier
- Brystkreft26 studier
- Metastatisk kreft25 studier
- Akut myelogen leukemi19 studier
- Eggstokkreft19 studier
- Autismespekterforstyrrelse17 studier
- Lungekreft17 studier
- Prostatakreft15 studier
- Hjertesvikt15 studier
- Autisme13 studier
- Akut lymfoblastisk leukemi13 studier
- Kolorektal kreft13 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.